{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:2244",
      "entity_text" : "aspirin",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:9875401",
      "entity_text" : "rivaroxaban",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Exemplary for this is that the COMPASS trial, investigating whether rivaroxaban alone or added to aspirin led to less cardiovascular events in comparison to aspirin alone, was halted after the interim analysis revealed superiority of the combined rivaroxaban plus aspirin in comparison to aspirin alone.",
  "reading_complete" : "2020-08-03T14:02:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:59:02Z",
  "trigger" : "led",
  "evidence" : [ "rivaroxaban alone or added to aspirin led to less cardiovascular events in comparison to aspirin" ],
  "pmc_id" : "6524908",
  "score" : 0
}